Global Antidiabetic Biguanides Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Antidiabetic Biguanides Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Antidiabetic Biguanides by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Antidiabetic Biguanides by Country/Region, 2017, 2022 & 2028

2.2 Antidiabetic Biguanides Segment by Type

2.2.1 Metformin IR

2.2.2 Metformin SR

2.3 Antidiabetic Biguanides Sales by Type

2.3.1 Global Antidiabetic Biguanides Sales Market Share by Type (2017-2022)

2.3.2 Global Antidiabetic Biguanides Revenue and Market Share by Type (2017-2022)

2.3.3 Global Antidiabetic Biguanides Sale Price by Type (2017-2022)

2.4 Antidiabetic Biguanides Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Other

2.5 Antidiabetic Biguanides Sales by Application

2.5.1 Global Antidiabetic Biguanides Sale Market Share by Application (2017-2022)

2.5.2 Global Antidiabetic Biguanides Revenue and Market Share by Application (2017-2022)

2.5.3 Global Antidiabetic Biguanides Sale Price by Application (2017-2022)

3 Global Antidiabetic Biguanides by Company

3.1 Global Antidiabetic Biguanides Breakdown Data by Company

3.1.1 Global Antidiabetic Biguanides Annual Sales by Company (2020-2022)

3.1.2 Global Antidiabetic Biguanides Sales Market Share by Company (2020-2022)

3.2 Global Antidiabetic Biguanides Annual Revenue by Company (2020-2022)

3.2.1 Global Antidiabetic Biguanides Revenue by Company (2020-2022)

3.2.2 Global Antidiabetic Biguanides Revenue Market Share by Company (2020-2022)

3.3 Global Antidiabetic Biguanides Sale Price by Company

3.4 Key Manufacturers Antidiabetic Biguanides Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Antidiabetic Biguanides Product Location Distribution

3.4.2 Players Antidiabetic Biguanides Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Antidiabetic Biguanides by Geographic Region

4.1 World Historic Antidiabetic Biguanides Market Size by Geographic Region (2017-2022)

4.1.1 Global Antidiabetic Biguanides Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Antidiabetic Biguanides Annual Revenue by Geographic Region

4.2 World Historic Antidiabetic Biguanides Market Size by Country/Region (2017-2022)

4.2.1 Global Antidiabetic Biguanides Annual Sales by Country/Region (2017-2022)

4.2.2 Global Antidiabetic Biguanides Annual Revenue by Country/Region

4.3 Americas Antidiabetic Biguanides Sales Growth

4.4 APAC Antidiabetic Biguanides Sales Growth

4.5 Europe Antidiabetic Biguanides Sales Growth

4.6 Middle East & Africa Antidiabetic Biguanides Sales Growth

5 Americas

5.1 Americas Antidiabetic Biguanides Sales by Country

5.1.1 Americas Antidiabetic Biguanides Sales by Country (2017-2022)

5.1.2 Americas Antidiabetic Biguanides Revenue by Country (2017-2022)

5.2 Americas Antidiabetic Biguanides Sales by Type

5.3 Americas Antidiabetic Biguanides Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Antidiabetic Biguanides Sales by Region

6.1.1 APAC Antidiabetic Biguanides Sales by Region (2017-2022)

6.1.2 APAC Antidiabetic Biguanides Revenue by Region (2017-2022)

6.2 APAC Antidiabetic Biguanides Sales by Type

6.3 APAC Antidiabetic Biguanides Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Antidiabetic Biguanides by Country

7.1.1 Europe Antidiabetic Biguanides Sales by Country (2017-2022)

7.1.2 Europe Antidiabetic Biguanides Revenue by Country (2017-2022)

7.2 Europe Antidiabetic Biguanides Sales by Type

7.3 Europe Antidiabetic Biguanides Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Antidiabetic Biguanides by Country

8.1.1 Middle East & Africa Antidiabetic Biguanides Sales by Country (2017-2022)

8.1.2 Middle East & Africa Antidiabetic Biguanides Revenue by Country (2017-2022)

8.2 Middle East & Africa Antidiabetic Biguanides Sales by Type

8.3 Middle East & Africa Antidiabetic Biguanides Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Antidiabetic Biguanides

10.3 Manufacturing Process Analysis of Antidiabetic Biguanides

10.4 Industry Chain Structure of Antidiabetic Biguanides

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Antidiabetic Biguanides Distributors

11.3 Antidiabetic Biguanides Customer

12 World Forecast Review for Antidiabetic Biguanides by Geographic Region

12.1 Global Antidiabetic Biguanides Market Size Forecast by Region

12.1.1 Global Antidiabetic Biguanides Forecast by Region (2023-2028)

12.1.2 Global Antidiabetic Biguanides Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Antidiabetic Biguanides Forecast by Type

12.7 Global Antidiabetic Biguanides Forecast by Application

13 Key Players Analysis

13.1 Pfizer

13.1.1 Pfizer Company Information

13.1.2 Pfizer Antidiabetic Biguanides Product Offered

13.1.3 Pfizer Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Pfizer Main Business Overview

13.1.5 Pfizer Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca Antidiabetic Biguanides Product Offered

13.2.3 AstraZeneca Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 GlaxoSmithKline

13.3.1 GlaxoSmithKline Company Information

13.3.2 GlaxoSmithKline Antidiabetic Biguanides Product Offered

13.3.3 GlaxoSmithKline Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 GlaxoSmithKline Main Business Overview

13.3.5 GlaxoSmithKline Latest Developments

13.4 Merck & Co

13.4.1 Merck & Co Company Information

13.4.2 Merck & Co Antidiabetic Biguanides Product Offered

13.4.3 Merck & Co Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merck & Co Main Business Overview

13.4.5 Merck & Co Latest Developments

13.5 Eli Lilly

13.5.1 Eli Lilly Company Information

13.5.2 Eli Lilly Antidiabetic Biguanides Product Offered

13.5.3 Eli Lilly Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Eli Lilly Main Business Overview

13.5.5 Eli Lilly Latest Developments

13.6 Sanofi

13.6.1 Sanofi Company Information

13.6.2 Sanofi Antidiabetic Biguanides Product Offered

13.6.3 Sanofi Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sanofi Main Business Overview

13.6.5 Sanofi Latest Developments

13.7 Takeda Pharmaceuticals

13.7.1 Takeda Pharmaceuticals Company Information

13.7.2 Takeda Pharmaceuticals Antidiabetic Biguanides Product Offered

13.7.3 Takeda Pharmaceuticals Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Takeda Pharmaceuticals Main Business Overview

13.7.5 Takeda Pharmaceuticals Latest Developments

13.8 Novo Nordisk

13.8.1 Novo Nordisk Company Information

13.8.2 Novo Nordisk Antidiabetic Biguanides Product Offered

13.8.3 Novo Nordisk Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Novo Nordisk Main Business Overview

13.8.5 Novo Nordisk Latest Developments

13.9 Servier Laboratories

13.9.1 Servier Laboratories Company Information

13.9.2 Servier Laboratories Antidiabetic Biguanides Product Offered

13.9.3 Servier Laboratories Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Servier Laboratories Main Business Overview

13.9.5 Servier Laboratories Latest Developments

13.10 Boehringer Ingelheim

13.10.1 Boehringer Ingelheim Company Information

13.10.2 Boehringer Ingelheim Antidiabetic Biguanides Product Offered

13.10.3 Boehringer Ingelheim Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Boehringer Ingelheim Main Business Overview

13.10.5 Boehringer Ingelheim Latest Developments

13.11 Bristol-Myers Squibb

13.11.1 Bristol-Myers Squibb Company Information

13.11.2 Bristol-Myers Squibb Antidiabetic Biguanides Product Offered

13.11.3 Bristol-Myers Squibb Antidiabetic Biguanides Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Bristol-Myers Squibb Main Business Overview

13.11.5 Bristol-Myers Squibb Latest Developments

14 Research Findings and Conclusion

Table 1. Antidiabetic Biguanides Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Antidiabetic Biguanides Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Metformin IR

Table 4. Major Players of Metformin SR

Table 5. Global Antidiabetic Biguanides Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Antidiabetic Biguanides Sales Market Share by Type (2017-2022)

Table 7. Global Antidiabetic Biguanides Revenue by Type (2017-2022) & ($ million)

Table 8. Global Antidiabetic Biguanides Revenue Market Share by Type (2017-2022)

Table 9. Global Antidiabetic Biguanides Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Antidiabetic Biguanides Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Antidiabetic Biguanides Sales Market Share by Application (2017-2022)

Table 12. Global Antidiabetic Biguanides Revenue by Application (2017-2022)

Table 13. Global Antidiabetic Biguanides Revenue Market Share by Application (2017-2022)

Table 14. Global Antidiabetic Biguanides Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Antidiabetic Biguanides Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Antidiabetic Biguanides Sales Market Share by Company (2020-2022)

Table 17. Global Antidiabetic Biguanides Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Antidiabetic Biguanides Revenue Market Share by Company (2020-2022)

Table 19. Global Antidiabetic Biguanides Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Antidiabetic Biguanides Producing Area Distribution and Sales Area

Table 21. Players Antidiabetic Biguanides Products Offered

Table 22. Antidiabetic Biguanides Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Antidiabetic Biguanides Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Antidiabetic Biguanides Sales Market Share Geographic Region (2017-2022)

Table 27. Global Antidiabetic Biguanides Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Antidiabetic Biguanides Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Antidiabetic Biguanides Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Antidiabetic Biguanides Sales Market Share by Country/Region (2017-2022)

Table 31. Global Antidiabetic Biguanides Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Antidiabetic Biguanides Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Antidiabetic Biguanides Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Antidiabetic Biguanides Sales Market Share by Country (2017-2022)

Table 35. Americas Antidiabetic Biguanides Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Antidiabetic Biguanides Revenue Market Share by Country (2017-2022)

Table 37. Americas Antidiabetic Biguanides Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Antidiabetic Biguanides Sales Market Share by Type (2017-2022)

Table 39. Americas Antidiabetic Biguanides Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Antidiabetic Biguanides Sales Market Share by Application (2017-2022)

Table 41. APAC Antidiabetic Biguanides Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Antidiabetic Biguanides Sales Market Share by Region (2017-2022)

Table 43. APAC Antidiabetic Biguanides Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Antidiabetic Biguanides Revenue Market Share by Region (2017-2022)

Table 45. APAC Antidiabetic Biguanides Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Antidiabetic Biguanides Sales Market Share by Type (2017-2022)

Table 47. APAC Antidiabetic Biguanides Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Antidiabetic Biguanides Sales Market Share by Application (2017-2022)

Table 49. Europe Antidiabetic Biguanides Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Antidiabetic Biguanides Sales Market Share by Country (2017-2022)

Table 51. Europe Antidiabetic Biguanides Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Antidiabetic Biguanides Revenue Market Share by Country (2017-2022)

Table 53. Europe Antidiabetic Biguanides Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Antidiabetic Biguanides Sales Market Share by Type (2017-2022)

Table 55. Europe Antidiabetic Biguanides Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Antidiabetic Biguanides Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Antidiabetic Biguanides Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Antidiabetic Biguanides Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Antidiabetic Biguanides Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Antidiabetic Biguanides Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Antidiabetic Biguanides Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Antidiabetic Biguanides Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Antidiabetic Biguanides Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Antidiabetic Biguanides Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Antidiabetic Biguanides

Table 66. Key Market Challenges & Risks of Antidiabetic Biguanides

Table 67. Key Industry Trends of Antidiabetic Biguanides

Table 68. Antidiabetic Biguanides Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Antidiabetic Biguanides Distributors List

Table 71. Antidiabetic Biguanides Customer List

Table 72. Global Antidiabetic Biguanides Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Antidiabetic Biguanides Sales Market Forecast by Region

Table 74. Global Antidiabetic Biguanides Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Antidiabetic Biguanides Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Antidiabetic Biguanides Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Antidiabetic Biguanides Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Antidiabetic Biguanides Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Antidiabetic Biguanides Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Antidiabetic Biguanides Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Antidiabetic Biguanides Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Antidiabetic Biguanides Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Antidiabetic Biguanides Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Antidiabetic Biguanides Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Antidiabetic Biguanides Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Antidiabetic Biguanides Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Antidiabetic Biguanides Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Antidiabetic Biguanides Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Antidiabetic Biguanides Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Antidiabetic Biguanides Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Antidiabetic Biguanides Revenue Market Share Forecast by Application (2023-2028)

Table 92. Pfizer Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 93. Pfizer Antidiabetic Biguanides Product Offered

Table 94. Pfizer Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Pfizer Main Business

Table 96. Pfizer Latest Developments

Table 97. AstraZeneca Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 98. AstraZeneca Antidiabetic Biguanides Product Offered

Table 99. AstraZeneca Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. AstraZeneca Main Business

Table 101. AstraZeneca Latest Developments

Table 102. GlaxoSmithKline Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 103. GlaxoSmithKline Antidiabetic Biguanides Product Offered

Table 104. GlaxoSmithKline Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. GlaxoSmithKline Main Business

Table 106. GlaxoSmithKline Latest Developments

Table 107. Merck & Co Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 108. Merck & Co Antidiabetic Biguanides Product Offered

Table 109. Merck & Co Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 110. Merck & Co Main Business

Table 111. Merck & Co Latest Developments

Table 112. Eli Lilly Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 113. Eli Lilly Antidiabetic Biguanides Product Offered

Table 114. Eli Lilly Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 115. Eli Lilly Main Business

Table 116. Eli Lilly Latest Developments

Table 117. Sanofi Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 118. Sanofi Antidiabetic Biguanides Product Offered

Table 119. Sanofi Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 120. Sanofi Main Business

Table 121. Sanofi Latest Developments

Table 122. Takeda Pharmaceuticals Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 123. Takeda Pharmaceuticals Antidiabetic Biguanides Product Offered

Table 124. Takeda Pharmaceuticals Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 125. Takeda Pharmaceuticals Main Business

Table 126. Takeda Pharmaceuticals Latest Developments

Table 127. Novo Nordisk Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 128. Novo Nordisk Antidiabetic Biguanides Product Offered

Table 129. Novo Nordisk Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 130. Novo Nordisk Main Business

Table 131. Novo Nordisk Latest Developments

Table 132. Servier Laboratories Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 133. Servier Laboratories Antidiabetic Biguanides Product Offered

Table 134. Servier Laboratories Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 135. Servier Laboratories Main Business

Table 136. Servier Laboratories Latest Developments

Table 137. Boehringer Ingelheim Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 138. Boehringer Ingelheim Antidiabetic Biguanides Product Offered

Table 139. Boehringer Ingelheim Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 140. Boehringer Ingelheim Main Business

Table 141. Boehringer Ingelheim Latest Developments

Table 142. Bristol-Myers Squibb Basic Information, Antidiabetic Biguanides Manufacturing Base, Sales Area and Its Competitors

Table 143. Bristol-Myers Squibb Antidiabetic Biguanides Product Offered

Table 144. Bristol-Myers Squibb Antidiabetic Biguanides Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 145. Bristol-Myers Squibb Main Business

Table 146. Bristol-Myers Squibb Latest Developments

List of Figures

Figure 1. Picture of Antidiabetic Biguanides

Figure 2. Antidiabetic Biguanides Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Antidiabetic Biguanides Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Antidiabetic Biguanides Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Antidiabetic Biguanides Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Metformin IR

Figure 10. Product Picture of Metformin SR

Figure 11. Global Antidiabetic Biguanides Sales Market Share by Type in 2021

Figure 12. Global Antidiabetic Biguanides Revenue Market Share by Type (2017-2022)

Figure 13. Antidiabetic Biguanides Consumed in Hospitals

Figure 14. Global Antidiabetic Biguanides Market: Hospitals (2017-2022) & (K Pcs)

Figure 15. Antidiabetic Biguanides Consumed in Clinics

Figure 16. Global Antidiabetic Biguanides Market: Clinics (2017-2022) & (K Pcs)

Figure 17. Antidiabetic Biguanides Consumed in Other

Figure 18. Global Antidiabetic Biguanides Market: Other (2017-2022) & (K Pcs)

Figure 19. Global Antidiabetic Biguanides Sales Market Share by Application (2017-2022)

Figure 20. Global Antidiabetic Biguanides Revenue Market Share by Application in 2021

Figure 21. Antidiabetic Biguanides Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Antidiabetic Biguanides Revenue Market Share by Company in 2021

Figure 23. Global Antidiabetic Biguanides Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Antidiabetic Biguanides Revenue Market Share by Geographic Region in 2021

Figure 25. Global Antidiabetic Biguanides Sales Market Share by Region (2017-2022)

Figure 26. Global Antidiabetic Biguanides Revenue Market Share by Country/Region in 2021

Figure 27. Americas Antidiabetic Biguanides Sales 2017-2022 (K Pcs)

Figure 28. Americas Antidiabetic Biguanides Revenue 2017-2022 ($ Millions)

Figure 29. APAC Antidiabetic Biguanides Sales 2017-2022 (K Pcs)

Figure 30. APAC Antidiabetic Biguanides Revenue 2017-2022 ($ Millions)

Figure 31. Europe Antidiabetic Biguanides Sales 2017-2022 (K Pcs)

Figure 32. Europe Antidiabetic Biguanides Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Antidiabetic Biguanides Sales 2017-2022 (K Pcs)

Figure 34. Middle East & Africa Antidiabetic Biguanides Revenue 2017-2022 ($ Millions)

Figure 35. Americas Antidiabetic Biguanides Sales Market Share by Country in 2021

Figure 36. Americas Antidiabetic Biguanides Revenue Market Share by Country in 2021

Figure 37. United States Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Antidiabetic Biguanides Sales Market Share by Region in 2021

Figure 42. APAC Antidiabetic Biguanides Revenue Market Share by Regions in 2021

Figure 43. China Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Antidiabetic Biguanides Sales Market Share by Country in 2021

Figure 50. Europe Antidiabetic Biguanides Revenue Market Share by Country in 2021

Figure 51. Germany Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Antidiabetic Biguanides Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Antidiabetic Biguanides Revenue Market Share by Country in 2021

Figure 58. Egypt Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Antidiabetic Biguanides Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Antidiabetic Biguanides in 2021

Figure 64. Manufacturing Process Analysis of Antidiabetic Biguanides

Figure 65. Industry Chain Structure of Antidiabetic Biguanides

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles